Show source-provided references
2. Du, D., Asaoka, T., Ushida, T., and Furukawa, K.S. (2014). Fabrication and perfusion culture of anatomically shaped artificial bone using stereolithography. Biofabrication, 6.
10.1088/1758-5082/6/4/045002 ↗3. Bone substitutes: A review of their characteristics, clinical use, and perspectives for large bone defects management
10.1177/2041731418776819 ↗6. Bioglass® stimulation of embryonic long-bones in altered loading environments
9. Bronzino, J.D., and Peterson, D.R. (2000). The Biomedical Engineering Handbook, CRC Press LLC. [2nd ed.].
10. Sergi, R., Bellucci, D., and Cannillo, V. (2020). A Comprehensive Review of Bioactive Glass Coatings: State of the Art, Challenges and Future Perspectives. Coatings, 10.
10.3390/coatings10080757 ↗12. Revolutionizing bone regeneration: 3D printing of PLA/MFBG composites with advanced healing properties
13. Garimella, A., Ghosh, S.B., and Bandyopadhyay-Ghosh, S. (2024). Biomaterials for bone tissue engineering: Achievements to date and future directions. Biomed. Mater., 20.
10.1088/1748-605X/ad967c ↗14. Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: A multi-center study
10.5194/jbji-6-413-2021 ↗15. Staphylococcus aureus colonization and periprosthetic joint infection in patients undergoing elective total joint arthroplasty: A narrative review
10.1530/EOR-23-0031 ↗17. Bioactive glass coatings on metallic implants for biomedical applications
19. (2023). Biological Evaluation of Medical Devices—Part 17: Toxicological Risk Assessment of Medical Device Constituents (Standard No. ISO 10993-17:2023).
20. Thangaraju, P., and Varthya, S.B. (2022). ISO 10993: Biological evaluation of medical devices. Medical Device Guidelines and Regulations Handbook, Springer International Publishing.
10.1007/978-3-030-91855-2_11 ↗21. U.S. Food and Drug Administration (2025, July 28). Use of International Standard ISO 10993-1: Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing Within a Risk Management Process, Available online: https://www.fda.gov/media/142959/download.
22. Anusavice, K.J. (1996). Phillips’ Science of Dental Materials, WB Saunders. [10th ed.].
23. Phenotypic stability of the human MG-63 osteoblastic cell line at different passages
10.1002/cbin.11073 ↗24. Bioresorption and Biomineralization of S53P4 Bioactive Glass in Neutral Tris Buffer and Citric Acid Solution
10.1021/acsomega.4c06020 ↗27. Adhesion and inactivation of Gram-negative and Gram-positive bacteria on photoreactive TiO2/polymer and Ag–TiO2/polymer nanohybrid films
10.1016/j.apsusc.2016.02.202 ↗28. Venkei, A., Ungvári, K., Eördegh, G., Janovák, L., Urbán, E., and Turzó, K. (2020). Photocatalytic enhancement of antibacterial effects of photoreactive nanohybrid films in an in vitro Streptococcus mitis model. Arch. Oral Biol., 117.
10.1016/j.archoralbio.2020.104837 ↗29. Investigation of the antibacterial effects of silver-modified TiO2 and ZnO plasmonic photocatalysts embedded in polymer thin films
10.1007/s11356-014-2568-6 ↗31. (2001). Biological Evaluation of Medical Devices–Part 14: Identification and Quantification of Degradation Products from Ceramics (Standard No. ISO 10993-14:2001).
34. MG-63 human osteosarcoma cells grown in monolayer and as three-dimensional tumor spheroids present a different metabolic profile